Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 5
1989 11
1990 39
1991 43
1992 38
1993 66
1994 86
1995 95
1996 90
1997 72
1998 103
1999 77
2000 63
2001 48
2002 45
2003 53
2004 42
2005 56
2006 50
2007 48
2008 45
2009 47
2010 58
2011 49
2012 66
2013 87
2014 67
2015 51
2016 70
2017 53
2018 48
2019 50
2020 39
2021 40
2022 35
2023 38
2024 25

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,856 results

Results by year

Filters applied: . Clear all
Page 1
Transdermal granisetron.
Duggan ST, Curran MP. Duggan ST, et al. Drugs. 2009;69(18):2597-605. doi: 10.2165/11202780-000000000-00000. Drugs. 2009. PMID: 19943709 Review.
Granisetron is a highly selective serotonin 5-HT(3) receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting. The transdermal granisetron system delivers continuous granisetron (3.1 mg/day) into the systemic circulation (via passive …
Granisetron is a highly selective serotonin 5-HT(3) receptor antagonist for the prevention of chemotherapy-induced nausea and vomitin …
Pharmacological augmentation of serotonin reuptake inhibitors in patients with obsessive-compulsive disorder: A network meta-analysis.
Maiti R, Mishra A, Srinivasan A, Mishra BR. Maiti R, et al. Acta Psychiatr Scand. 2023 Jul;148(1):19-31. doi: 10.1111/acps.13568. Epub 2023 May 12. Acta Psychiatr Scand. 2023. PMID: 37177823 Review.
RESULTS: The drugs showing significant reduction in YBOCS scoring were pregabalin (MD:-8.1;95% CrI: -16, -0.43), memantine (MD:-6.2;95% CrI: -9.9, -2.3), lamotrigine (MD:-6;95% CrI: -12, -0.47), ondansetron (MD:-5.7;95% CrI: -11, -0.67), granisetron (MD:-5.6;95% CrI: -11, …
RESULTS: The drugs showing significant reduction in YBOCS scoring were pregabalin (MD:-8.1;95% CrI: -16, -0.43), memantine (MD:-6.2;95% CrI: …
Biochronomer technology.
Heller J, Barr J. Heller J, et al. Expert Opin Drug Deliv. 2005 Jan;2(1):169-83. doi: 10.1517/17425247.2.1.169. Expert Opin Drug Deliv. 2005. PMID: 16296743
A low molecular semisolid polymer is now in Phase II clinical trials for the delivery of mepivacaine to control postoperative pain, and in Phase I clinical trials for the systemic delivery of granisetron to control nausea....
A low molecular semisolid polymer is now in Phase II clinical trials for the delivery of mepivacaine to control postoperative pain, and in P …
Surrogate outcomes: meaningful not!
Fisher DM. Fisher DM. Anesthesiology. 1999 Feb;90(2):355-6. doi: 10.1097/00000542-199902000-00003. Anesthesiology. 1999. PMID: 9952135 Free article. No abstract available.
Granisetron in the treatment of chemotherapy-induced nausea and vomiting (CINV) - is there still a role after comparison with palonosetron?
Doggrell SA. Doggrell SA. Expert Opin Pharmacother. 2017 Jul;18(10):1019-1026. doi: 10.1080/14656566.2017.1342809. Epub 2017 Jun 19. Expert Opin Pharmacother. 2017. PMID: 28612633 Review.
Area covered: In an attempt to maintain plasma levels of granisetron during the delayed phase of CINV, longer-acting preparations of granisetron have been manufactured. ...At present, it seems likely that there will be ongoing roles for intravenous and subcutaneous …
Area covered: In an attempt to maintain plasma levels of granisetron during the delayed phase of CINV, longer-acting preparations of …
Granisetron: is there a dose-response effect on nausea and vomiting?
Minami M. Minami M. Cancer Chemother Pharmacol. 2003 Aug;52(2):89-98. doi: 10.1007/s00280-003-0652-6. Epub 2003 May 29. Cancer Chemother Pharmacol. 2003. PMID: 12783208 Review.
The aim of this article is to examine the hypothesis that there is a dose-response effect of granisetron for preventing chemotherapy-induced nausea and vomiting in cancer patients. METHODS: A literature review of relevant publications was undertaken to provide a comprehens …
The aim of this article is to examine the hypothesis that there is a dose-response effect of granisetron for preventing chemotherapy- …
Granisetron.
Nodoushani M. Nodoushani M. Conn Med. 1995 Apr;59(4):209-11. Conn Med. 1995. PMID: 7606907 Review. No abstract available.
Efficacy of palonosetron in postoperative nausea and vomiting (PONV)-a meta-analysis.
Singh PM, Borle A, Gouda D, Makkar JK, Arora MK, Trikha A, Sinha A, Goudra B. Singh PM, et al. J Clin Anesth. 2016 Nov;34:459-82. doi: 10.1016/j.jclinane.2016.05.018. Epub 2016 Jun 28. J Clin Anesth. 2016. PMID: 27687434 Review.
In early phase, palonosetron had better VI and CR than did granisetron; however, variables other than CR (better for palonosetron) failed to achieve statistical significance for delayed phase. ...CONCLUSION: Palonosetron is as safe as and more effective than placebo, ramos …
In early phase, palonosetron had better VI and CR than did granisetron; however, variables other than CR (better for palonosetron) fa …
Granisetron: a review of pharmacokinetics and clinical experience in chemotherapy induced - nausea and vomiting.
Spartinou A, Nyktari V, Papaioannou A. Spartinou A, et al. Expert Opin Drug Metab Toxicol. 2017 Dec;13(12):1289-1297. doi: 10.1080/17425255.2017.1396317. Epub 2017 Oct 27. Expert Opin Drug Metab Toxicol. 2017. PMID: 29057666 Review.
Areas covered: In this review the authors provide a detailed description of granisetron's chemistry pharmacokinetics, pharmacodynamics, toxicity and a brief review of clinical trials involving granisetron and the management of CINV. ...Expert opinion: According to c …
Areas covered: In this review the authors provide a detailed description of granisetron's chemistry pharmacokinetics, pharmacodynamic …
Granisetron: the second serotonin-receptor antagonist.
Adams VR, Valley AW. Adams VR, et al. Ann Pharmacother. 1995 Dec;29(12):1240-51. doi: 10.1177/106002809502901211. Ann Pharmacother. 1995. PMID: 8672830 Review.
DATA SOURCES: MEDLINE (1966-1995) and CANCERLIT (1991-1995) searches of English-language literature using the terms "granisetron" and "granisetron (rn)" were performed. STUDY SELECTION AND DATA EXTRACTION: All articles were considered for possible inclusion in this …
DATA SOURCES: MEDLINE (1966-1995) and CANCERLIT (1991-1995) searches of English-language literature using the terms "granisetron" and …
1,856 results